<DOC>
	<DOCNO>NCT02275702</DOCNO>
	<brief_summary>The propose study randomize , double-blind , placebo-controlled evaluation small dose IV dexamethasone induction anesthesia association pre postoperative intercostal nerve block , improve quality recovery thoracoscopic lung resection patient .</brief_summary>
	<brief_title>Randomized Study Preoperative Dexamethasone Quality Recovery VATS Lung Resection Patients</brief_title>
	<detailed_description>This study compose 2 group 50 patient undergoing VATS lung cancer . All subjets receive intraoperative intercostal nerve block maximum dose 2 mg/kg bupivacaine epinephrine 1:200.000 begin end procedure . The control group receive bolus dose dexamethasone ( 0.1 mg/kg ) placebo group saline solution . The study drug placebo administer time anesthetic induction ( approximately 30 minute surgical incision ) . Patients evaluate daily quality recovery questionary , visual analogue pain portable spirometry . And , patient pulmonary lung function assess portable spirometry .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>resectable stage I II lung cancer patient submit VATS american society anesthesiology Classification ( ASA ) I II chronic pain ; chronic analgesic consumption ; severe renal liver disease ; endocrine mental disease ; poorly control diabetes ; allergy bupivacaine ; previous thoracotomy ; systemic use corticosteroid ; morbid obesity ; poor French comprehension preclude completion QoR40 questionnaire ; patient refusal .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Dexamethasone</keyword>
	<keyword>Quality recovery questionnaire</keyword>
	<keyword>QoR-40</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>Video-assisted thoracoscopic</keyword>
</DOC>